Blue Crest Capital Management LTD Edwards Lifesciences Corp Transaction History

Blue Crest Capital Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $413,677 - $506,965	-6,721 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $1.08 Million - $1.25 Million	-19,379 Reduced 74.25%	6,721 $1.24 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $1.25 Million - $1.67 Million	26,100 New	26,100 $4.99 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $66,273 - $81,310	-1,428 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $342,750 - $435,225	-7,500 Reduced 84.01%	1,428 $249,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $5,645 - $6,822	-133 Reduced 1.47%	8,928 $1.3 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $336,978 - $429,944	9,061 New	9,061 $1.26 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.